1. Amiodarone-related acute respiratory distress syndrome following sudden withdrawal of steroids.
- Author
-
Charles PE, Doise JM, Quenot JP, Muller G, Aube H, Baudouin N, Piard F, Besancenot JF, and Blettery B
- Subjects
- Aged, Amiodarone administration & dosage, Anti-Arrhythmia Agents administration & dosage, Bronchoalveolar Lavage Fluid cytology, Bronchoalveolar Lavage Fluid microbiology, Fatal Outcome, Humans, Lung pathology, Male, Neutrophils metabolism, Papilledema chemically induced, Pneumonia chemically induced, Pneumonia pathology, Respiration, Artificial, Respiratory Distress Syndrome therapy, Shock, Septic microbiology, Staphylococcal Infections complications, Adrenal Cortex Hormones therapeutic use, Amiodarone adverse effects, Anti-Arrhythmia Agents adverse effects, Methylprednisolone therapeutic use, Papilledema drug therapy, Respiratory Distress Syndrome chemically induced
- Abstract
Acute lung toxicity is a rare but classical complication of amiodarone therapy. We report the case of a patient who developed an optic neuropathy after 15 years of amiodarone administration, and who was treated for 2 weeks with steroids. Following withdrawal of steroids, the patient rapidly developed an acute respiratory distress syndrome. Postmortem lung histologic examination was consistent with amiodarone-induced pneumonitis. Since this complication is thought to be of immunological origin, we speculate that the sudden withdrawal of steroids was implicated in the development of the acute lung injury.
- Published
- 2006
- Full Text
- View/download PDF